Organon

At Organon, we believe in the power of collaboration to create lasting change. Our Her Plan is Her Power initiative focuses on improving maternal health by partnering with communities around the globe. 🤝🌍 Discover how these partnerships are making a difference and learn more about our commitment to maternal health here: https://ogn.llc/6042W0jfa #HerPlanHerPower #MaternalHealth #CommunityPartnerships #HealthcareInnovation

Every year, RESOLVE: The National Infertility Association’s Night of Hope Gala celebrates strides in advocating for #infertility care and highlights the challenges faced by many, while honoring the passionate individuals and organizations that bring RESOLVE’s mission to life. Organon is committed to championing care equity in fertility. By collaborating with providers, advocates, like RESOLVE, and communities, we are working to elevate fertility awareness and expand resources to help more aspiring parents access the care they deserve. #NOH2024

The Misses of Health Information are here to keep it real. Women often need to juggle roles, responsibilities and pressures which can worsen gaps in pay, health and overall care. Addressing these gaps can potentially help improve women’s lives today, and change how future generations of women receive support. At Organon, we’re committed to bringing awareness, investment, and scientific expertise to the healthcare ecosystem supporting the health of women. #MissesofHealthInformation #MissInformation #MissUnderstood #MissDiagnosis #PayEquity #HealthEquity #WomensHealth

Dr. Charlotte Owens, MD, FACOG, Organon’s Head of Medical Affairs & Outcomes Research, spoke at the #FierceBiotechSummit on the topic of Empowering Women’s Health through Biotech Innovation and Research. The discussion focused on the impact investment in women’s health can have on society as a whole. Increasing awareness of women’s health, including and beyond sexual and reproductive health, can not only help women thrive but also help their families, communities, and economies. Our mini mic team met Dr. Owens afterwards to get her key takeaways. #WomensHealth #Biotech24 Fierce Life Sciences Events

On this International Men’s Day, let’s celebrate the men at Organon who champion gender equality and support the women in their lives. Your dedication to creating an inclusive environment is vital to our vision of a healthier every day for every woman.

#Biosimilars have the potential to play a vital role in making health care more accessible and affordable for people with certain conditions. Learn more about how biosimilars may provide cost-effective alternatives to originator biologics.

Our next feature in “Minds Behind the Science” spotlights Allison Armstrong, PhD, an Asset Development Team Leader at Organon who oversees the strategic development of new therapies.  From early inspirations in science and rare diseases to driving real-world change in women’s health, Allison’s work is centered around empathy, passion, and innovation. Her journey from drug discovery to clinical development began with a pivotal moment early in her career when she attended a patient and family caregiver meeting for rare pediatric metabolic diseases. From that point, her work wasn’t just about the science; it was about the patients living with these diseases every day.  Today, her team is working on a program that aims to bring more treatment options to women with polycystic ovary syndrome (PCOS)—a condition which affects an ‘estimated 8–13% of women of reproductive age, and up to 70% of affected women remain undiagnosed worldwide, according to the World Health Organization (WHO). “Everyone you talk to at Organon has this drive to improve the treatment options available for women’s health conditions,” Allison says. Listen to how her teamwork-centered approach helps drive innovation at Organon, where the focus is always on delivering important therapies to patients around the world. #MindsBehindTheScience #WomenInScience #PolycysticOvarySyndrome #PCOS #WomensHealth

#Biosimilars have the potential to increase competition in the health care marketplace. With increased competition, biosimilars may help to expand choice and access to biologic medications. Learn more about the potential benefits to patients and the health care system: https://ogn.llc/6048WmDrO #GlobalBiosimilarsWeek #GBW24 #Biosimilar

The Misses of Health Information are back to break down the cost of being a woman. The first step toward understanding this impact is widening our definition of women’s health. At Organon, we believe women’s health is far too narrowly defined, as many definitions reduce women’s health needs to reproductive health only. Our definition encompasses the health of the whole woman across her life as some women’s health conditions may be interconnected with others. #MissesofHealthInformation #MissDiagnosis #MissInformation #HealthEquity #WomensHealth

Misinformation about contraception and reproductive care is a growing health concern. Confusion, information overload, and myths flood our screens, feeds and conversations on a daily basis which can influence the decision-making process. Inaccurate information can potentially contribute to higher unintended pregnancy rates and misunderstandings about birth control – this can be detrimental to women and their community. Part of Organon’s aim is to help ensure quality care and fact-based access to information for women and girls. By educating about reproductive health, we strive to inspire, empower, and uplift. Learn more from Dr. Charlotte Owens, MD, FACOG, Head of Medical Affairs & Outcomes Research at Organon, in the The New York Times: https://ogn.llc/6009WYjOd #WomensHealth #ReproductiveHealth